Exchange: NSE·Updated 04:00 PM GMT+5:30

INDOCO.NSE News

News
all
press releases
Indoco Remedies gets USFDA nod to sell generic epilepsy medicine
Indoco Remedies has secured approval from the US health regulator for its generic Lacosamide oral solution. This medication is used to treat epilepsy in adults and children. The approval allows Indoco Remedies to market the drug, which is a generic version of Vimpat Oral Solution. Manufacturing will take place at their Goa facility.
cityfalcon.com
For now, Goa’s pharma industry remains unaffected by US tariffs
… The tariffs are for branded drugs; pharma companies in the state export … said. According to the pharma industry body, presently 95 … strict,” they said. Geno Pharmaceuticals Pvt Ltd founder Dilip … Indoco Remedies Ltd, Sun Pharmaceuticals and Lupin. The US …
cityfalcon.com
Indoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing facility
… Certificate for EU Good Manufacturing Practices (GMP) Compliance … its sterile drug product manufacturing facility, Goa Plant … complies with the Good Manufacturing Practice requirements. Commenting … our sterile drug product manufacturing facility, Goa Plant …
cityfalcon.com
Indoco Remedies Limited - 7/26/2024
Indoco Remedies Limited - 7/26/2024. Country: India. Record Type: 483
cityfalcon.com

Advertisement|Remove ads.